Clinical Trial Update: Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial examines molecular marker profiling of axillary lymph nodes to predict response to chemotherapy in locally advanced or metastatic br…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED